Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,789,782,319
+$131,583,508 QoQ
Shares Held
29,996,694
+14.3% QoQ
Ownership
2.42%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#9
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $40,270,584,407 across 16 Drug Manufacturers - General names. GILD ranks #3 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,911,839 | $16,686,278,442 | |
| 2 | JNJ |
Johnson & Johnson
|
22,996,878 | $5,840,517,105 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
29,996,694 | $3,789,782,319 | |
| 4 | ABBV |
AbbVie Inc.
|
14,749,069 | $3,711,455,722 | |
| 5 | AZN |
Astrazeneca PLC
|
16,616,629 | $3,150,845,190 | |
| 6 | MRK |
Merck & Co., Inc.
|
18,518,796 | $2,379,665,285 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
31,707,643 | $1,826,994,388 | |
| 8 | AMGN |
Amgen Inc
|
3,956,992 | $1,432,905,943 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,789,782,319 | 29,996,694 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,658,198,811 | 26,248,108 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,399,733,527 | 27,698,660 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,941,876,401 | 26,503,391 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,615,056,542 | 23,586,692 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,647,482,691 | 14,703,103 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $327,610,618 | 3,546,721 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $280,712,501 | 3,348,193 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $195,224,814 | 2,845,428 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $182,576,649 | 2,492,514 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $228,569,714 | 2,821,500 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $170,153,217 | 2,270,526 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $240,585,179 | 3,121,645 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $205,549,379 | 2,477,394 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $206,901,761 | 2,410,038 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $101,976,900 | 1,653,054 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $127,161,156 | 2,057,291 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $148,726,362 | 2,501,705 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $198,216,296 | 2,729,876 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $250,403,239 | 3,584,871 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $360,446,568 | 5,234,484 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $349,502,882 | 5,407,750 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $373,490,877 | 6,410,760 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $510,707,330 | 8,082,091 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $680,656,403 | 8,846,587 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $828,375,114 | 11,080,459 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||